This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hornia, A.
Right arrow Articles by Foster, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hornia, A.
Right arrow Articles by Foster, D. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 1999, p. 7672-7680, Vol. 19, No. 11
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Antagonistic Effects of Protein Kinase C alpha  and delta  on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor

Armand Hornia, Zhimin Lu, Taiko Sukezane, Minghao Zhong, Troy Joseph, Paul Frankel, and David A. Foster*

Department of Biological Sciences, Hunter College of The City University of New York, New York, New York 10021

Received 13 August 1998/Returned for modification 4 November 1998/Accepted 23 June 1999

Downregulation of protein kinase C delta  (PKC delta ) by treatment with the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) transforms cells that overexpress the non-receptor class tyrosine kinase c-Src (Z. Lu et al., Mol. Cell. Biol. 17:3418-3428, 1997). We extended these studies to cells overexpressing a receptor class tyrosine kinase, the epidermal growth factor (EGF) receptor (EGFR cells); like c-Src, the EGF receptor is overexpressed in several human tumors. In contrast with expectations, downregulation of PKC isoforms with TPA did not transform the EGFR cells; however, treatment with EGF did transform these cells. Since TPA downregulates all phorbol ester-responsive PKC isoforms, we examined the effects of PKC delta - and PKC alpha -specific inhibitors and the expression of dominant negative mutants for both PKC delta  and alpha . Consistent with a tumor-suppressing function for PKC delta , the PKC delta -specific inhibitor rottlerin and a dominant negative PKC delta  mutant transformed the EGFR cells in the absence of EGF. In contrast, the PKC alpha -specific inhibitor Go6976 and expression of a dominant negative PKC alpha  mutant blocked the transformed phenotype induced by both EGF and PKC delta  inhibition. Interestingly, both rottlerin and EGF induced substantial increases in phospholipase D (PLD) activity, which is commonly elevated in response to mitogenic stimuli. The elevation of PLD activity in response to inhibiting PKC delta , like transformation, was dependent upon PKC alpha  and restricted to the EGFR cells. These data demonstrate that PKC isoforms alpha  and delta  have antagonistic effects on both transformation and PLD activity and further support a tumor suppressor role for PKC delta  that may be mediated by suppression of tyrosine kinase-dependent increases in PLD activity.

* Corresponding author. Mailing address: Department of Biological Sciences, Hunter College of The City University of New York, 695 Park Ave., New York, NY 10021. Phone: (212) 772-4075. Fax: (212) 772-5227. E-mail: foster{at}genectr.hunter.cuny.edu.

Molecular and Cellular Biology, November 1999, p. 7672-7680, Vol. 19, No. 11
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sonoda, H., Okada, T., Jahangeer, S., Nakamura, S.-i. (2007). Requirement of Phospholipase D for Ilimaquinone-induced Golgi Membrane Fragmentation. J. Biol. Chem. 282: 34085-34092 [Abstract] [Full Text]  
  • Shukla, A., Barrett, T. F., Nakayama, K. I., Nakayama, K., Mossman, B. T., Lounsbury, K. M. (2006). Transcriptional up-regulation of MMP12 and MMP13 by asbestos occurs via a PKC{delta}-dependent pathway in murine lung. FASEB J. 20: 997-999 [Abstract] [Full Text]  
  • Rodrik, V., Zheng, Y., Harrow, F., Chen, Y., Foster, D. A. (2005). Survival Signals Generated by Estrogen and Phospholipase D in MCF-7 Breast Cancer Cells Are Dependent on Myc. Mol. Cell. Biol. 25: 7917-7925 [Abstract] [Full Text]  
  • Hampson, P., Chahal, H., Khanim, F., Hayden, R., Mulder, A., Assi, L. K., Bunce, C. M., Lord, J. M. (2005). PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood 106: 1362-1368 [Abstract] [Full Text]  
  • Hui, L., Abbas, T., Pielak, R. M., Joseph, T., Bargonetti, J., Foster, D. A. (2004). Phospholipase D Elevates the Level of MDM2 and Suppresses DNA Damage-Induced Increases in p53. Mol. Cell. Biol. 24: 5677-5686 [Abstract] [Full Text]  
  • JACKSON, D. N., FOSTER, D. A. (2004). The enigmatic protein kinase C{delta}: complex roles in cell proliferation and survival. FASEB J. 18: 627-636 [Abstract] [Full Text]  
  • Abbas, T., White, D., Hui, L., Yoshida, K., Foster, D. A., Bargonetti, J. (2004). Inhibition of Human p53 Basal Transcription by Down-regulation of Protein Kinase C{delta}. J. Biol. Chem. 279: 9970-9977 [Abstract] [Full Text]  
  • Foster, D. A., Xu, L. (2003). Phospholipase D in Cell Proliferation and Cancer. Mol Cancer Res 1: 789-800 [Abstract] [Full Text]  
  • Kambhampati, S., Li, Y., Verma, A., Sassano, A., Majchrzak, B., Deb, D. K., Parmar, S., Giafis, N., Kalvakolanu, D. V., Rahman, A., Uddin, S., Minucci, S., Tallman, M. S., Fish, E. N., Platanias, L. C. (2003). Activation of Protein Kinase C{delta} by All-trans-retinoic Acid. J. Biol. Chem. 278: 32544-32551 [Abstract] [Full Text]  
  • Jang, I. H., Lee, S., Park, J. B., Kim, J. H., Lee, C. S., Hur, E.-M., Kim, I. S., Kim, K.-T., Yagisawa, H., Suh, P.-G., Ryu, S. H. (2003). The Direct Interaction of Phospholipase C-gamma 1 with Phospholipase D2 Is Important for Epidermal Growth Factor Signaling. J. Biol. Chem. 278: 18184-18190 [Abstract] [Full Text]  
  • Ahn, B.-H., Kim, S. Y., Kim, E. H., Choi, K. S., Kwon, T. K., Lee, Y. H., Chang, J.-S., Kim, M.-S., Jo, Y.-H., Min, D. S. (2003). Transmodulation between Phospholipase D and c-Src Enhances Cell Proliferation. Mol. Cell. Biol. 23: 3103-3115 [Abstract] [Full Text]  
  • Nelson, E. J., Hellevuo, K., Yoshimura, M., Tabakoff, B. (2003). Ethanol-induced Phosphorylation and Potentiation of the Activity of Type 7 Adenylyl Cyclase. INVOLVEMENT OF PROTEIN KINASE C delta. J. Biol. Chem. 278: 4552-4560 [Abstract] [Full Text]  
  • Xu, L., Frankel, P., Jackson, D., Rotunda, T., Boshans, R. L., D'Souza-Schorey, C., Foster, D. A. (2003). Elevated Phospholipase D Activity in H-Ras- but Not K-Ras-Transformed Cells by the Synergistic Action of RalA and ARF6. Mol. Cell. Biol. 23: 645-654 [Abstract] [Full Text]  
  • Han, J. M., Kim, Y., Lee, J. S., Lee, C. S., Lee, B. D., Ohba, M., Kuroki, T., Suh, P.-G., Ryu, S. H. (2002). Localization of Phospholipase D1 to Caveolin-enriched Membrane via Palmitoylation: Implications for Epidermal Growth Factor Signaling. Mol. Biol. Cell 13: 3976-3988 [Abstract] [Full Text]  
  • Keshamouni, V. G., Mattingly, R. R., Reddy, K. B. (2002). Mechanism of 17-beta -Estradiol-induced Erk1/2 Activation in Breast Cancer Cells. A ROLE FOR HER2 AND PKC-delta. J. Biol. Chem. 277: 22558-22565 [Abstract] [Full Text]  
  • Ren, J., Li, Y., Kufe, D. (2002). Protein Kinase C delta Regulates Function of the DF3/MUC1 Carcinoma Antigen in beta -Catenin Signaling. J. Biol. Chem. 277: 17616-17622 [Abstract] [Full Text]  
  • Min, D. S., Kwon, T. K., Park, W.-S., Chang, J.-S., Park, S.-K., Ahn, B.-H., Ryoo, Z.-Y., Lee, Y. H., Lee, Y. S., Rhie, D.-J., Yoon, S.-H., Hahn, S. J., Kim, M.-S., Jo, Y.-H. (2001). Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 22: 1641-1647 [Abstract] [Full Text]  
  • Zhong, M., Lu, Z., Abbas, T., Hornia, A., Chatakondu, K., Barile, N., Kaplan, P., Foster, D. A. (2001). Novel Tumor-promoting Property of Tamoxifen. Cell Growth Differ. 12: 187-192 [Abstract] [Full Text]  
  • Shen, Y., Xu, L., Foster, D. A. (2001). Role for Phospholipase D in Receptor-Mediated Endocytosis. Mol. Cell. Biol. 21: 595-602 [Abstract] [Full Text]  
  • Lu, Z., Hornia, A., Joseph, T., Sukezane, T., Frankel, P., Zhong, M., Bychenok, S., Xu, L., Feig, L. A., Foster, D. A. (2000). Phospholipase D and RalA Cooperate with the Epidermal Growth Factor Receptor To Transform 3Y1 Rat Fibroblasts. Mol. Cell. Biol. 20: 462-467 [Abstract] [Full Text]  
  • Xu, A., Wang, Y., Xu, L. Y., Gilmour, R. S. (2001). Protein Kinase C alpha -mediated Negative Feedback Regulation Is Responsible for the Termination of Insulin-like Growth Factor I-induced Activation of Nuclear Phospholipase C beta 1 in Swiss 3T3 Cells. J. Biol. Chem. 276: 14980-14986 [Abstract] [Full Text]  
  • Soltoff, S. P. (2001). Rottlerin Is a Mitochondrial Uncoupler That Decreases Cellular ATP Levels and Indirectly Blocks Protein Kinase Cdelta Tyrosine Phosphorylation. J. Biol. Chem. 276: 37986-37992 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»